Free Trial

Benchmark (LON:BMK) Trading Up 7.1% - Still a Buy?

Benchmark logo with Consumer Defensive background

Key Points

  • Benchmark Holdings plc shares increased by 7.1% during mid-day trading, reaching a high of GBX 24 and closing at GBX 22.
  • The company reported a negative EPS of GBX (1.77) (($0.02)) and has a market cap of £163.08 million.
  • Benchmark focuses on enhancing sustainability and profitability for aquaculture producers by developing innovative products that improve yield, quality, and animal health.
  • MarketBeat previews top five stocks to own in September.

Benchmark Holdings plc (LON:BMK - Get Free Report) was up 7.1% during trading on Tuesday . The company traded as high as GBX 24 ($0.32) and last traded at GBX 22 ($0.29). Approximately 104,582 shares changed hands during mid-day trading, a decline of 66% from the average daily volume of 304,879 shares. The stock had previously closed at GBX 20.55 ($0.27).

Benchmark Stock Up 13.6%

The business has a 50 day moving average of GBX 23.93 and a 200 day moving average of GBX 24.34. The company has a debt-to-equity ratio of 33.02, a current ratio of 1.73 and a quick ratio of 1.41. The firm has a market capitalization of £179.39 million, a price-to-earnings ratio of -4.54, a price-to-earnings-growth ratio of -19.62 and a beta of 0.69.

Benchmark (LON:BMK - Get Free Report) last issued its earnings results on Thursday, June 12th. The company reported GBX (1.77) (($0.02)) EPS for the quarter. Benchmark had a negative net margin of 43.67% and a negative return on equity of 16.05%. On average, equities analysts anticipate that Benchmark Holdings plc will post 0.9566873 EPS for the current year.

Benchmark Company Profile

(Get Free Report)

Benchmark's mission is to enable aquaculture producers to improve their sustainability and profitability.We bring together biology and technology to develop innovative products which improve yield, quality and animal health and welfare for our customers. We do this by improving the genetic make-up, health and nutrition of their stock - from broodstock and hatchery through to nursery and grow out. Benchmark has a broad portfolio of products and solutions, including salmon eggs, live feed (artemia), diets and probiotics and sea lice treatments.

Further Reading

Should You Invest $1,000 in Benchmark Right Now?

Before you consider Benchmark, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Benchmark wasn't on the list.

While Benchmark currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in August 2025
The $2.5B Merger No One Is Talking About
ALERT: Big Tech Earnings – Watch Before Wednesday

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines